⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
The Weather Company and Health Action Alliance Join Forces to Strengthen Business Preparedness Amid Weather's Increasing Impact
prnewswire.com
GOOGL
DIS
CVS
BMY
MMC
Health Monitor Network Appoints Jay Korada as Vice President, Data Analytics, Research & Insights
globenewswire.com
BMY
ABBV
More Than 100 Technology Leaders Registered for HMG Strategy's 19th Annual Greenwich C-Level Technology Leadership Summit on October 15
globenewswire.com
PEP
MA
BMY
CHTR
CSCO
CRWD
OTIS
PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
globenewswire.com
TMO
AGNC
QGEN
EXAS
LH
DGX
BNTX
CRSP
REGN
GILD
AMGN
BMY
MRK
PFE
ABBV
LLY
AZN
SNY
NVS
BIIB
VRTX
BMRN
IDXX
CRWD
DDOG
SNOW
NVDA
AMD
INTC
MSFT
QDEL
MYGN
SENS
INM
PRPO
CODX
BFC
BSY
NCL
ABT
DHR
BDX
BIO
BRKR
CTAS
CUE
HOLX
Global Cell & Gene Therapy Market Size and Forecast Report 2026-2036 | Market to Reach US$126.86 Billion at 17.3% CAGR as CRISPR, CAR-T and Scalable Manufacturing Drive Growth
globenewswire.com
ALLO
ATRA
BEAM
BMRN
BMY
CRSP
GILD
INTC
JNJ
NVS
VRTX
Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 67 Billion as Targeted Therapies Drive 6.6% CAGR
globenewswire.com
PFE
MRK
JNJ
LLY
BMY
AZN
REGN
VRTX
RMD
BIIB
GILD
AMGN
ABBV
VERU
The Mark Foundation Awards $12 Million to Cross-Disciplinary Cancer Research Teams
prnewswire.com
NVS
MRK
BMY
GILD
AZN
PFE
JNJ
BIIB
REGN
MDLZ
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
globenewswire.com
BMY
MRK
Acute Myocardial Infarction (AMI) - Market Insights, Epidemiology, and Market Forecast Now Available; Acute Myocardial Infarction (AMI) Market Projected to Reach Approximately USD 6.00 Billion by 2036
globenewswire.com
AMGN
MRK
REGN
AZN
PFE
BMY
JNJ
VTRS
CELC
NVO
ARWR
Global Precision Medicine Market Size, Share, Growth, and Forecast 2026-2035 | AI, Genomics, and Targeted Therapies Drive 11.10% CAGR Toward USD 468.56 Billion by 2035
globenewswire.com
PFE
JNJ
AMGN
ILMN
BMY
DHR
BIIB